Paid Clinical Trials in Whittier, CA
As of July 2026, 30 paid clinical trials are recruiting in Whittier, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Whittier offers studies at sites including GSK Investigational Site for conditions such as Breast Cancer, Psoriatic Arthritis, Anemia, Rheumatoid Arthritis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Whittier
Trials by drug in Whittier
Filter results
28 clinical trials
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Study of GS-0151 in Participants With Rheumatoid Arthritis
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
ConsideRAte Study - Splenic Stimulation for RA
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Acupuncture and Chinese Herbal Medicine for Long COVID
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Top Research Study Locations in Whittier
Researchers run research studies in Whittier, CA at 23 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| GSK Investigational Site | Gastrointestinal Neoplasms, Multiple Myeloma, Systemic Lupus Erythematosus | 3 |
| Innovative Clinical Research Institute | Lymphoid Malignancies, Metastatic Castration-Resistant Prostate Cancer, Metastatic Pancreatic Adenocarcinoma | 3 |
| PIH Health Whittier Hospital | Breast Cancer, Colorectal Cancer, Early Stage Breast Cancer | 3 |
| Medvin Clinical Research | Psoriatic Arthritis, Rheumatoid Arthritis | 2 |
| Cancer & Blood Research Center | Anemia, Myelodysplastic Syndrome | 1 |
| Cancer and Blood Specialty Clinic | Anemia, Myelofibrosis | 1 |
| Clinical Trial Site | Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer | 1 |
| Helios Clinical Research | Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, Triple Negative Breast Neoplasms | 1 |
| Local Institution - 007-898-A | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Medvin Clinical Research - Whittier | Overweight or Obesity, Psoriatic Arthritis | 1 |
| Medvin Clinical Research-Whittier-69033 | Systemic Sclerosis | 1 |
| Medvin Research - Whittier | Rheumatoid Arthritis | 1 |
| PIH Health | Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer | 1 |
| PIH Health Hospital | Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma | 1 |
| PIH Health Hospital - Whittier | Atrial Fibrillation, Intracerebral Hemorrhage | 1 |
| PIH Health Hospital - Whittier Hospital | Breast Cancer | 1 |
| PIH Health Whittier Hospital & PIH Health Physicians | Cancer | 1 |
| PIH Whittier Hospital | Chronic Limb-Threatening Ischemia | 1 |
| Pa0019 120 | Axial Spondyloarthritis, Psoriatic Arthritis | 1 |
| Pa0019 128 | Axial Spondyloarthritis, Psoriatic Arthritis | 1 |
| Pih Health Hematology Medical Oncology | Recurrent or Metastatic Solid Tumors | 1 |
| Presbyterian Intercommunity Hospital Health Whitter Hospital | Extensive Stage Small-cell Lung Cancer, Small-cell Lung Cancer | 1 |
| SCUHS | Long COVID | 1 |
Active & Upcoming Studies in Whittier (2026)
Recruiting trials in Whittier grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (13 active studies)
- A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM) · Phase 2 · GlaxoSmithKline
- Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies · Tempus AI
Vaccines (1 active study)
- Acupuncture and Chinese Herbal Medicine for Long COVID · Southern California University of Health Sciences
Diabetes & metabolic (1 active study)
Cardiovascular (1 active study)
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Common conditions studied in Whittier
- Breast Cancer (3 active studies)
- Psoriatic Arthritis (3 active studies)
- Anemia (2 active studies)
- Rheumatoid Arthritis (2 active studies)
- Advanced Breast Cancer (1 active study)
- Advanced Non-Small Cell Lung Cancer (1 active study)
Leading research sponsors in Whittier
- Takeda
- GlaxoSmithKline
- Tempus AI
- AVM Biotechnology Inc
- Amgen
Frequently asked questions
How many paid clinical trials are currently recruiting in Whittier?
There are approximately 30 recruiting clinical trials in Whittier, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Whittier pay participants?
Most recruiting trials in Whittier compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Whittier?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Whittier?
The most common conditions under active study in Whittier include Breast Cancer (3), Psoriatic Arthritis (3), Anemia (2), Rheumatoid Arthritis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Whittier?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Whittier on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Whittier?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Whittier?
Recruiting research sites in Whittier include GSK Investigational Site, Innovative Clinical Research Institute, PIH Health Whittier Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Whittier right now?
The largest active categories in Whittier are Cancer & tumors (13), Vaccines (1), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.